Los Angeles Capital Management’s bluebird bio BLUE Stock Holding History

Los Angeles Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-4,857	Closed	-$320K	–	1128
2023 Q2	$320K	Buy	4,857 +75	+2%	+$5.49K	﹤0.01%	975
2023 Q1	$304K	Sell	4,782 -1,529	-24%	-$175K	﹤0.01%	1002
2022 Q4	$873K	Buy	+6,311	New	+$889K	﹤0.01%	741
2020 Q4	–	Sell	-3,935	Closed	-$2.75M	–	1510
2020 Q3	$2.75M	Sell	3,935 -659	-14%	-$514K	0.01%	491
2020 Q2	$3.63M	Buy	+4,594	New	+$3.46M	0.02%	468
2019 Q2	–	Sell	-2,747	Closed	-$5.6M	–	1347
2019 Q1	$5.6M	Buy	2,747 +1,838	+202%	+$3.24M	0.03%	413
2018 Q4	$1.17M	Sell	909 -1,414	-61%	-$2.17M	0.01%	686
2018 Q3	$4.39M	Sell	2,323 -8,106	-78%	-$16.7M	0.02%	479
2018 Q2	$21.2M	Buy	10,429 +9,061	+662%	+$20.7M	0.12%	218
2018 Q1	$3.02M	Buy	1,368 +568	+71%	+$1.44M	0.02%	535
2017 Q4	$1.84M	Buy	800 +436	+120%	+$885K	0.01%	690
2017 Q3	$648K	Buy	+364	New	+$509K	﹤0.01%	943

Other funds holding BLUE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Los Angeles Capital Management's BLUE Position: Q3 2023 in Review

Los Angeles Capital Management sold out of bluebird bio (BLUE) in Q3 2023, closing a stake of 4,857 shares — an estimated $320K sold.

Los Angeles Capital Management first reported a position in BLUE in Q3 2017 and held it in 12 quarters. The position peaked at $21.2M in Q2 2018. 168 funds tracked by Wall St. Rank hold BLUE as of Q3 2023.

Los Angeles Capital Management reported no remaining bluebird bio position as of Q3 2023 after selling out during the quarter.
Los Angeles Capital Management sold 4,857 bluebird bio shares in Q3 2023, an estimated $320K.
Los Angeles Capital Management first reported a position in bluebird bio in Q3 2017 and held it in 12 quarters.
Los Angeles Capital Management's bluebird bio position peaked at $21.2M in Q2 2018.
168 funds tracked by Wall St. Rank held bluebird bio as of Q3 2023.

Based on Los Angeles Capital Management's 13F filing for Q3 2023, filed 6 Nov 2023.